The board authorized the expenditure of funds for share repurchases. Given the remaining amount under the board’s March 2019 $6B authorization was $1.9B by the end of the last fiscal quarter, the board today authorized an incremental $5B for share repurchases. The company noted that there is no specific time period associated with this repurchase authorization.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MDT:
- Medtronic files ITC action against Axonics
- Orchestra BioMed presents new data on long-term effect of AVIM therapy
- Medtronic participates in a conference call with JPMorgan
- Medtronic price target raised to $90 from $87 at Truist
- Medtronic price target raised to $75 from $72 at UBS
Questions or Comments about the article? Write to editor@tipranks.com